Insys Therapeutics has launched its marijuana drug Syndros. However, uncertainty over demand for it and ongoing concerns regarding the marketing … Read More
The post Why This Marijuana Stock Crashed 18.5% in August appeared first on Dagga Magazine.
Insys Therapeutics has launched its marijuana drug Syndros. However, uncertainty over demand for it and ongoing concerns regarding the marketing … Read More
The post Why This Marijuana Stock Crashed 18.5% in August appeared first on Dagga Magazine.